Immunochemical identification of branched-chain 2-oxo acid dehydrogenase kinase  by Shimomura, Yoshiharu et al.
Volume 288, number I,& 95-97 FEBS 10052 
0 1991 F&ration of European Biochemical Societies Ob145793/91/$3.50 
ADONIS 00144793910076OP 
August 1991 
Immunochemical identification of branched=-chain 24x0 acid 
dehydrogenase kinase 
Yoshiharu Shimomura’, Noriko Nanaumil, Masashige Suzuki’ and Robert A. Harris2 
1 Laboratory of Biochemistry of Exercise and Nutrition, Institute of Health and Sport Sciences, University of T’sukuba, Tsukuba, 
Ibaraki 30.7, Japan and 2Department of Biochemistry and Molecular Biology. Indiana University School of Medicirle, 
635 Barnhiil Drive, Indianapolis, IN 46202-5122. USA 
Received 24 May 1991 
Branched-chain 2-0~0 acid dehydrogenasc kinase was characterized using anti-kinase polyclonal antibodies. The antibodies were purified from rab- 
bit antiserum by an epitope selection method. The antibodies bound only to a 44 kDa polypeptide in the dehydrogenase-kinase complex and inhibit- 
ed the kinase activity, substantiating that the 44 kDa polypeptide is the catalytic subunit of the kinase. The purified liver dehydrogenase-kinase 
complex, but not either the purified heart complex or the partially purified liver complex, contained 2 additional polypeptides of lower molecular 
weight which also reacted with the anti-kinase antibodies, suggesting that the liver kinase is subject to proteolytic degradation during purification. 
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1. INTRODUCTION 
Branched-chain 2-0~0 acid dehydrogenase (BCODH) 
complex (EC 1.2.4.4. + dihydrolipoamide acyltrans- 
ferase (no EC number) + EC 1.8.1.4) is the rate-limiting 
enzyme in the catabolism of branched-chain amino 
acids (valine, leucine and isoleucine) [l]. This enzyme 
complex is subject to regulation by covalent modifica- 
tion. BCODH kinase (no EC number) is responsible for 
phosphorylation and inactivation of the Ela compo- 
nent of the complex 12-51. Recently, we have purified 
BCODH kinase from rat liver and rat heart and partial- 
ly characterized the kinase [6]. In this paper, we report 
further characterization of the kinase using 
monospecific anti-kinase polyclonal antibodies. 
2. MATERIALS AND METHODS 
2.1, Materials 
Rat heart and liver BCODH-kinase complex, BCODH kinase and 
kinnse-depleted BCODH were prepared as described in [6]. Anli- 
kinasc antibodies were orcpared by immunization of a rabbit with the 
purified heart kinase preparation as dcscribcd in [7] except that the 
4th injection of the antigen was omitted, and the antibodies wcrc 
purified from the antiserum by the cpitopc sclcction method of Kelly 
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et al. 181. For the study of the kinase in rapidly purified liver BCODH- 
kinase complex, 4 male Sprague-Dawley rats (CLEA Japan. Tokyo) 
with initial body weights of 150-164 g were fed ad libitum a semi- 
synthetic diet containing 5% casein for 2 weeks. The animals were im- 
mobilized by cervical dislocation and livers removed and freeze- 
clamped (< 10 s) at the temperature of liquid nitrogen. Other 
materials used were described in [b]. 
2.2. Methods 
BCODH complex was partially purified from livers of rats fed the 
diet described above for Western blot analyses; BCODH complex was 
extracted from livers as described in [9] and was purified by a one cy- 
clc of Phenyl-Sepharose column chromatography (using a 2 ml col- 
umn) and polyethylene glycol precipitation as described in [IO]. SDS- 
PAGE was performed by the method of Laemmli [ll]. Samples for 
electrophoresis were treated as described in [IO]. Electroblotting of 
SDS-PAGE gels and immunostaining of blotted filters were carried 
out as described in 1121. BCODH activity was spectrophotomctrically 
measured as described in [IO]. Protein determination was by the BCA 
method using bovine serum albumin as a standard 1131. 
3. RESULTS AND DISCUSSION 
3.1. Specificity of the purified anti-kinase antibodies 
The specificity of the purified anti-kinase antibodies 
was examined by Western blot analysis. The purified 
antibodies bound only to the 44 kDa polypeptide in the 
heart BCODH-kinase complex preparation (Fig, IB, 
lane 2). Kinase-depleted BCODH complex from the 
liver BCODH-kinase complex preparation showed only 
a faint band at 44 kDa in the analysis (Fig. IB, lane 4). 
On the othc: hand, the purified liver BCODH-kinase 
complex preparation contained 3 polypeptides which 
reacted with the purified antibodies; one was the 44 kDa 
polypcptidc and the others were polypcptidcs with 
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Fig. 1. Specificity of purified anti-kinase antibodies examined by Western dlot analysis. Lane I, almost purified heart kinase (0.6 rg); lane 2. 
purified heart BCODH-kinase complex (2/g); lane 3. purified liver BCODH-kinase complex (tpg); lane 4, liver kinase-depleted BCODH complex 
(2 pg), Proteins were resolved by SDS-PAGE. The proteins on blotted filters were detected by Coomassie blue staining (panel A) or by immunos- 
taining with the purified anti-kinase antibodies (panel 6). The 44 kDa polypeptide was considered to bc BCODH kinase in the previous paper [6]. 
slightly lower molecular weights than 44 kDa (Fig. IB, 
lane 3). Two independently purified preparations of the 
liver BCODH-kinase complex contained the same three 
immunoreactive protein bands. To examine whether 
these three polypeptides actually exist in intact rat liver 
or correspond to an artifact of liver BCODH-kinase 
complex purification, partially purified BCODH com- 
plex preparations were obtained from freeze-cIamped 
rat livers. In our routine purification procedure for the 
BCODH-kinase complex [6], the livers are not freeze- 
clamped at the temperature of liquid nitrogen and, fur- 
ther, the liver extracts are incubated at 30°C for 50 min 
to fully activate the BCODH complex. Since it is possi- 
ble that kinase protein could be degraded proteolytical- 
ly, even when incubations were conducted in the 
presence of protease inhibitors, an experiment was car- 
ried out in which the livers were freeze-clamped and the 
incubation step was omitted during partial purification 
of the BCODH-kinase complex. As shown in Fig. 2, 
such preparations from rat livers contained only one 
band (44 kDa) which reacted with the purified an- 
tibodies, suggesting that the two polypeptides of lower 
molecular weight (Fig. lB, lane 3) are proteolytic 
degradation products of the kinase produced during 
complete purification of the complex. Thus, it is 
reasonable to conclude that the purified antibodies 
generated for this study were specific for the 44 kDa 
polypeptide in the BCODH-kinasc complexes of both 
rat liver and heart. 
3,2. Effect of the specific antibodies on kitrase activity 
The effect of the purified antibodies on the KODH 
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Fig. 2. Wcstcrn blot atlalysls of partially purified UCODH son~plcx 
from rat livers. 0.4.1rg of the purified heart kinasc (lane I) and 5O/rg 
of ~hc partially purlficd I~CODH so~nplcx from 4 rat livers (lancr 2-s) 
wcrc subjcctcd to SDS-PAGE. 
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Fig. 3. Effect of the purified anti-kinase antibodies on the BCODH 
kinase activity. Purified liver BCODH-kinase (0.7 pg in 10 al) was 
mixed with different amounts of the purified antibodies in the 
antibody-eludng buffer (indicated volumes) or with the eluting buffer 
without antibodies as a control. The mixtures were flushed with NZ 
gas and then kept at 4°C for 24 h. The mixtures were finally made to 
2OO/rl by addition of 22.5,~g of kinase-depleted BCODH complex and 
buffer consisting of 20 mM HEPES, I.5 mM MgCIz, SO mM K~HPOJ 
and 2 mM dithiothreitol (pH 7.35 with NaOH). After pre-incubation 
at 30°C for 2 min. ATP (0.5 mM) was added and samples (20~1) were 
taken at 0.5, I and I.5 min directly into an assay mixture for BCODH 
activity. The kinase activity was expressed as a first order rate cons- 
tant of BCODH inactivation. 
kinase activity was examined in a reconstituted system 
consisting of the purified kinase plus kinase-depleted 
BCODH. Kinase activity was inhibited in an antibody 
dose-dependent manner, with approximately 65% in- 
hibition being obtained as the maximal inhibition in this 
experiment (Fig. 3). In order to examine whether this 
amount of antibodies was sufficient to bind to all of the 
kinase protein under sonditions of maximum inhibi- 
tion, a mixture of the antibodies and kinase at the same 
ratio as that giving the maximum inhibition was sub- 
jected to immunoadsorption chromatography on a pro- 
tein A-Sepharose column. Less than 4% of the kinase 
passed through the column, indicating that the an- 
tibodies bound to almost all the kinase protein and 
thereby substantiating that the 44 kDa polypeptide cor- 
responds to the catalytic subunit of BCODH kinase. 
AcknowledgemeNs: This work was supported by grants from the 
U.S. Public Health Services (NIH DK 19259) and the Grace M. 
Showaltcr Residuary Trust to R.A.H.. and the University of Tsukuba 
Project Research Fund to Y.S. 
REFERENCES 
VI 
VI 
131 
[41 
I51 
161 
171 
PI 
PI 
[lOI 
1111 
1121 
[I31 
Harper. A.E.. Miller, R.H. and Block, K.P. (1984) Annu. Rev. 
Nutr. 4. 409-459. 
Fatania, H., Lau, KS. and Randle. P.J. (1981) FEBS Lett. 132. 
285-288. 
Paxton, R. and Harris, R.A. (1982) J. Biol. Chem. 257, 
14433-14439. 
Odessey. R. (1982) Biochem. J. 204, 353-356. 
Lawson, R., Cook, K.G. and Yeaman. S.J. (1983) FEBS Lett. 
157, 54-58. 
Shimomura, Y., Nanaumi. N., Suzuki, M., Popov. K.M. and 
Harris, R.A. (1990) Arch. Biochem. Biophys. 283, 293-299. 
Shimomura, Y., Nishikimi. M. and Ozawa, T. (1986) Anal. 
Biochem. 153, 126-131. 
Kelly, J.L.. Greenleaf. A.L. and Lehman, I.R. (1986) J. Biol. 
Chem. 261. 10348-1986. 
Shimomura, Y., Suzuki, T.. Saitoh, S., Tasaki, Y., Harris, R.A. 
and Suzuki, M. (1990) J. Appl. Physiol. 68, 161-165. 
Shimomura, Y., Paxton, R., Ozawa, T. and Harris, R.A. (1987) 
Anal. Biochem. 163, 74-78. 
Laemmli, U.K. (1970) Nature 227, 680-685. 
Nishikimi, M., Shinromura, Y. and Ozawa, T. (1985) J. Biol. 
Chem. 260, 10398-10401. 
Smith, P.K., Krohn, R.I.. Hermanson, G.T., Mallia, A.K., 
Gartner, F.H., Provenzano, M.D., Fujimoto, E.K., Goeke, 
N.M., Olson, B.J. and Klenk, D.C. (1985) Anal. Biochem. 150, 
76-85. 
97 
